XBiotech Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2014 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
XBiotech Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2014 to Q2 2024.
- XBiotech Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$25K, a 135% decline year-over-year.
- XBiotech Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $136K, a 95.6% decline year-over-year.
- XBiotech Inc. annual Income Tax Expense (Benefit) for 2023 was $244K.
- XBiotech Inc. annual Income Tax Expense (Benefit) for 2022 was -$688K, a 91.4% increase from 2021.
- XBiotech Inc. annual Income Tax Expense (Benefit) for 2021 was -$8.04M, a 401% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)